| Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque ZD Drobni, RM Alvi, J Taron, A Zafar, SP Murphy, PK Rambarat, ... Circulation 142 (24), 2299-2311, 2020 | 342 | 2020 |
| Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week RC Mosarla, M Vaduganathan, A Qamar, J Moslehi, G Piazza, ... Journal of the American College of Cardiology 73 (11), 1336-1349, 2019 | 164 | 2019 |
| Efficacy and safety of nonvitamin K oral anticoagulants in patients with atrial fibrillation and cancer: a study-level meta-analysis I Cavallari, G Verolino, S Romano, G Patti Thrombosis and haemostasis 120 (02), 314-321, 2020 | 48 | 2020 |
| Aortic Stiffness: Epidemiology, Risk Factors, and Relevant Biomarkers CWT Rebecca Angoff, Ramya C Mosarla Front Cardiovasc Med . 8, 2021 | 44 | 2021 |
| The incidence, risk factors, and outcomes with 5-fluorouracil–associated coronary vasospasm A Zafar, ZD Drobni, R Mosarla, RM Alvi, M Lei, UY Lou, VK Raghu, ... Cardio Oncology 3 (1), 101-109, 2021 | 44 | 2021 |
| Drosophila Nipped-B Mutants Model Cornelia de Lange Syndrome in Growth and Behavior Y Wu, M Gause, D Xu, Z Misulovin, CA Schaaf, RC Mosarla, E Mannino, ... PLoS Genetics 11 (11), e1005655, 2015 | 38 | 2015 |
| Appropriate use of intravascular ultrasound during arterial and venous lower extremity interventions EA Secemsky, RC Mosarla, K Rosenfield, M Kohi, M Lichtenberg, ... Cardiovascular Interventions 15 (15), 1558-1568, 2022 | 30 | 2022 |
| Open access publishing and subsequent citations among articles in major cardiovascular journals RB Patel, M Vaduganathan, RC Mosarla, RV Venkateswaran, DL Bhatt, ... The American journal of medicine 132 (9), 1103-1105, 2019 | 22 | 2019 |
| Pre-existing autoimmune disease increases the risk of cardiovascular and noncardiovascular events after immunotherapy C Lee, ZD Drobni, A Zafar, CA Gongora, DA Zlotoff, RM Alvi, J Taron, ... Cardio Oncology 4 (5), 660-669, 2022 | 14 | 2022 |
| Intravascular ultrasound in peripheral venous and arterial interventions: A contemporary systematic review and grading of the quality of evidence S Natesan, RC Mosarla, SA Parikh, K Rosenfield, J Suomi, D Chalyan, ... Vascular Medicine 27 (4), 392-400, 2022 | 13 | 2022 |
| The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm A Zafar, ZD Drobni, M Lei, CA Gongora, T Quinaglia, UY Lou, R Mosarla, ... PLoS One 17 (4), e0265767, 2022 | 12 | 2022 |
| Outcomes associated with peripheral artery disease in myocardial infarction with cardiogenic shock N Mihatov, RC Mosarla, AJ Kirtane, SA Parikh, K Rosenfield, S Chen, ... Journal of the American College of Cardiology 79 (13), 1223-1235, 2022 | 9 | 2022 |
| Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors ZD Drobni, SP Murphy, RM Alvi, C Lee, J Gong, RC Mosarla, ... Immunotherapy Advances 1 (1), ltab014, 2021 | 9 | 2021 |
| Coexisting systemic infections in patients hospitalized because of a fall: prevalence and risk factors FA Manian, F Hsu, D Huang, A Blair, R Mosarla, W Mulugeta, M Lipartia The Journal of emergency medicine 58 (5), 733-740, 2020 | 8 | 2020 |
| State-of-the-art endovascular therapies for the femoropopliteal segment: are we there yet? RC Mosarla, E Armstrong, Y Bitton-Faiwiszewski, PA Schneider, ... Journal of the Society for Cardiovascular Angiography & Interventions 1 (5 …, 2022 | 7 | 2022 |
| The impact of depression and anxiety on cardiovascular disease risk and outcomes in women RC Mosarla, M Wood Current Treatment Options in Cardiovascular Medicine 23, 1-12, 2021 | 6 | 2021 |
| Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque., 2020, 142 ZD Drobni, RM Alvi, J Taron, A Zafar, SP Murphy, PK Rambarat, ... DOI: https://doi. org/10.1161/CIRCULATIONAHA 120, 2299-2311, 0 | 5 | |
| Endovascular Interventions for Peripheral Artery Disease: A Contemporary Review NW Watson, RC Mosarla, Eric A Secemsky Current Cardiology Reports, 2023 | 3 | 2023 |
| Cardiovascular and cerebrovascular events among patients receiving immune checkpoint inhibitors R Alvi, Z Drobni, A Zafar, L Zhang, J Taron, D Zlotoff, A Rokicki, VK Raghu, ... Journal of the American College of Cardiology 75 (11_Supplement_1), 36-36, 2020 | 2 | 2020 |
| SOLUBLE P-SELECTIN, PLATELET ACTIVITY AND RISK OF MORBIDITY AND MORTALITY IN COVID-19 JB Ramya Mosarla, Khrystyna Myndzar, Yuhe Xia, Tessa Barrett J Am Coll Cardiol. 79, 2022 | 1 | 2022 |
